Net Deals Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Novartis - Wikipedia

    en.wikipedia.org/wiki/Novartis

    Novartis. / 47.5744252; 7.5764914. Pharmaceutical drugs, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health ( list...) Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical ...

  3. Chiron Corporation - Wikipedia

    en.wikipedia.org/wiki/Chiron_Corporation

    Chiron Corporation ( / ˈkaɪrɒn / KY-ron) [1] was an American multinational biotechnology firm founded in 1981, based in Emeryville, California, that was acquired by Novartis on April 20, 2006. It had offices and facilities in eighteen countries on five continents. Chiron's business and research was in three main areas: biopharmaceuticals ...

  4. Alcon - Wikipedia

    en.wikipedia.org/wiki/Alcon

    Alcon Inc. ( German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people. [2]

  5. Novartis in advanced talks to buy Cytokinetics- source - AOL

    www.aol.com/news/novartis-advanced-talks-buy...

    Vontobel pharmaceuticals analyst Stefan Schneider said a deal made sense for Novartis, with Cytokinetics active in the cardiovascular field, one of the Swiss company's five main therapeutic areas.

  6. Vasant Narasimhan - Wikipedia

    en.wikipedia.org/wiki/Vasant_Narasimhan

    Vasant "Vas" Narasimhan (born August 26, 1976) is an American physician and the chief executive officer of Novartis. He succeeded Joseph Jimenez who left Novartis in 2018. He briefly worked at McKinsey before joining Novartis in 2005, where he has held a range of leadership roles, including Global Head of Development for Novartis Vaccines and Global Head of Drug Development & Chief Medical ...

  7. Novartis to acquire cancer-focused MorphoSys for $2.9 billion

    www.aol.com/news/novartis-acquire-cancer-drug...

    (Reuters) -Drugmaker Novartis AG said it will acquire MorphoSys AG, a developer of cancer treatments, for 2.7 billion euros ($2.9 billion), adding a promising rare bone-marrow cancer treatment ...

  8. Sandoz - Wikipedia

    en.wikipedia.org/wiki/Sandoz

    Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. [4] Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until ...

  9. Category:Novartis - Wikipedia

    en.wikipedia.org/wiki/Category:Novartis

    Syngenta. Categories: Biotechnology companies. Multinational companies headquartered in Switzerland. Pharmaceutical companies of Switzerland. Vaccine producers. Veterinary medicine companies. Manufacturing companies based in Basel. Life sciences industry.